HDEL Antibodies

Santa Cruz Biotechnology offers a broad range of HDEL Antibodies for targeting the HDEL sequence, a crucial marker for proteins retained in the endoplasmic reticulum. Monoclonal HDEL Antibodies support multiple research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). The HDEL sequence is essential for the retention of proteins within the endoplasmic reticulum, playing a significant role in protein folding and quality control. Understanding the dynamics of HDEL-tagged proteins is vital for elucidating cellular processes related to protein synthesis and secretion. Research focusing on HDEL proteins can provide insights into various diseases linked to protein misfolding and retention. Scientists studying cellular stress responses often monitor HDEL-tagged proteins as indicators of endoplasmic reticulum stress. Investigating HDEL-mediated protein retention mechanisms helps reveal fundamental aspects of cellular homeostasis. HDEL research has highlighted important connections between protein trafficking and various pathological conditions. Santa Cruz Biotechnology monoclonal HDEL Antibodies enable researchers worldwide to advance understanding of protein retention mechanisms and their impact on human health.